These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
257 related items for PubMed ID: 8122366
1. Reduced signal transduction through glucocorticoid receptor in Burkitt's lymphoma cell lines. Sinclair AJ, Jacquemin MG, Brooks L, Shanahan F, Brimmell M, Rowe M, Farrell PJ. Virology; 1994 Mar; 199(2):339-53. PubMed ID: 8122366 [Abstract] [Full Text] [Related]
2. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype. Nilsson T, Sjöblom A, Masucci MG, Rymo L. Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755 [Abstract] [Full Text] [Related]
3. Efficient EBV superinfection of group I Burkitt's lymphoma cells distinguishes requirements for expression of the Cp viral promoter and can activate the EBV productive cycle. Evans TJ, Jacquemin MG, Farrell PJ. Virology; 1995 Feb 01; 206(2):866-77. PubMed ID: 7856099 [Abstract] [Full Text] [Related]
4. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines. Pokrovskaja K, Ehlin-Henriksson B, Bartkova J, Bartek J, Scuderi R, Szekely L, Wiman KG, Klein G. Cell Growth Differ; 1996 Dec 01; 7(12):1723-32. PubMed ID: 8959341 [Abstract] [Full Text] [Related]
5. Regulation of interleukin-1beta transcription by Epstein-Barr virus involves a number of latent proteins via their interaction with RBP. Krauer KG, Belzer DK, Liaskou D, Buck M, Cross S, Honjo T, Sculley T. Virology; 1998 Dec 20; 252(2):418-30. PubMed ID: 9878621 [Abstract] [Full Text] [Related]
6. Cell phenotype-dependent splicing reflecting differential promoter usage for EBNA transcripts in EBV-carrying cells. Hu LF, Chen F, Altiok E, Winberg G, Klein G, Ernberg I. Gan To Kagaku Ryoho; 2000 May 20; 27 Suppl 2():248-60. PubMed ID: 10895161 [Abstract] [Full Text] [Related]
7. Modulation of expression of insulin and IGF-I receptor by Epstein-Barr virus and its gene products LMP and EBNA-2 in lymphocyte cell lines. Kriauciunas KM, Goldstein BJ, Lipes MA, Kahn CR. J Cell Physiol; 1993 Mar 20; 154(3):486-95. PubMed ID: 8382208 [Abstract] [Full Text] [Related]
8. Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines. Kube D, Platzer C, von Knethen A, Straub H, Bohlen H, Hafner M, Tesch H. Cytokine; 1995 Jan 20; 7(1):1-7. PubMed ID: 7749063 [Abstract] [Full Text] [Related]
9. Differential expression of nucleoskeleton- and cytoskeleton-associated proteins in Burkitt lymphoma-derived and Epstein-Barr virus-immortalized lymphoblastoid cell lines. Szekely L, Pokrovskaja K, Klein G. Cell Growth Differ; 1997 May 20; 8(5):599-609. PubMed ID: 9149911 [Abstract] [Full Text] [Related]
10. Influence of Epstein-Barr virus latent gene expression on the apoptosis-inducing effects of cortisone and 2-chlorodeoxyadenosine (2-CDA) in B-cell lines. Röth A, Pfaff P, Lange W, Finke J. Cytokines Mol Ther; 1996 Mar 20; 2(1):21-8. PubMed ID: 9384686 [Abstract] [Full Text] [Related]
11. Epstein-Barr virus encoded BALF1 gene is transcribed in Burkitt's lymphoma cell lines and in nasopharyngeal carcinoma's biopsies. Cabras G, Decaussin G, Zeng Y, Djennaoui D, Melouli H, Broully P, Bouguermouh AM, Ooka T. J Clin Virol; 2005 Sep 20; 34(1):26-34. PubMed ID: 16087121 [Abstract] [Full Text] [Related]
12. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication. Van Scoy S, Watakabe I, Krainer AR, Hearing J. Virology; 2000 Sep 15; 275(1):145-57. PubMed ID: 11017796 [Abstract] [Full Text] [Related]
13. Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells. Wolf J, Pawlita M, Klevenz B, Frech B, Freese UK, Müller-Lantzsch N, Diehl V, zur Hausen H. Int J Cancer; 1993 Feb 20; 53(4):621-7. PubMed ID: 8382194 [Abstract] [Full Text] [Related]
14. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. Gregory CD, Rowe M, Rickinson AB. J Gen Virol; 1990 Jul 20; 71 ( Pt 7)():1481-95. PubMed ID: 2165133 [Abstract] [Full Text] [Related]
15. Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes. Finke J, Fritzen R, Ternes P, Trivedi P, Bross KJ, Lange W, Mertelsmann R, Dölken G. Blood; 1992 Jul 15; 80(2):459-69. PubMed ID: 1378321 [Abstract] [Full Text] [Related]
16. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines. Gibbons DL, Rowe M, Cope AP, Feldmann M, Brennan FM. Eur J Immunol; 1994 Aug 15; 24(8):1879-85. PubMed ID: 8056047 [Abstract] [Full Text] [Related]
17. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection. Callahan J, Pai S, Cotter M, Robertson ES. Virology; 1999 Sep 15; 262(1):18-30. PubMed ID: 10489337 [Abstract] [Full Text] [Related]
18. Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells. Jochner N, Eick D, Zimber-Strobl U, Pawlita M, Bornkamm GW, Kempkes B. EMBO J; 1996 Jan 15; 15(2):375-82. PubMed ID: 8617212 [Abstract] [Full Text] [Related]
19. Expression of the chemokine receptor BLR2/EBI1 is specifically transactivated by Epstein-Barr virus nuclear antigen 2. Burgstahler R, Kempkes B, Steube K, Lipp M. Biochem Biophys Res Commun; 1995 Oct 13; 215(2):737-43. PubMed ID: 7488016 [Abstract] [Full Text] [Related]